This is a pooled fund: many plans invest in it, and it holds the underlying securities.
This filing is a Direct Filing Entity (DFE) — a master trust or collective investment trust that pools assets from multiple participating plans. It does not have plan participants of its own, and the Plan Health Score formula doesn’t apply. Individual participant-facing plans that invest in this trust are the appropriate target for fiduciary analysis.
Cited interest vs pooled assets: cited interest sums what each participating plan reported holding in this trust, measured at that plan’s own year-end — and those filings span different years. Pooled assets is this single filing’s balance at one date. They’re independent measurements, so cited interest can land slightly above or below the pooled balance and won’t reconcile exactly.
Why no Schedule of Assets here? DFE holdings often live on the master trust’s own audited statement, not as a 4i schedule on the participating plans’ filings. We’re extending the parsing pipeline to cover DFE filings — see Methodology.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $2.6M | — |
| KPMG LLP | 13-5565207 | — | NONE | $315K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $17K | — |
| MAPLES AND CALDER | — | — | NONE | $16K | — |
| T. ROWE PRICE ASSOCIATES, INC. | 52-0556948 | — | NONE | $9K | — |
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| ACP Investment Fund III | — | — | $17.0M | $28.8M | 6.0% | |
| AH Bio Fund II | — | — | $13.1M | $26.5M | 5.5% | |
| The Resolute Fund IV | — | — | $7.3M | $24.6M | 5.1% | |
| Parthenon Investors V | — | — | $7.7M | $22.9M | 4.8% |
| CRV XVII | — | — | $8.6M | $20.6M | 4.3% |
| ABRY Partners IX | — | — | $15.9M | $20.5M | 4.3% |
| Andreessen Horowitz Fund V | — | — | $7.8M | $19.6M | 4.1% |
| Water Street Healthcare Partners IV LP | — | — | $7.7M | $16.6M | 3.5% |
| Thoma Bravo XIII | — | — | $9.7M | $16.2M | 3.4% |
| Industrial Opportunity Partners III | — | — | $11.7M | $16.0M | 3.3% |
| Accel-KKR Growth Capital Partners III LP | — | — | $12.4M | $15.6M | 3.3% |
| HCI Equity Partners V | — | — | $9.5M | $15.6M | 3.3% |
| AH Parallel Fund V | — | — | $4.2M | $15.3M | 3.2% |
| Clayton, Dubilier & Rice Fund X | — | — | $9.3M | $14.1M | 2.9% |
| New Mountain Partners V | — | — | $9.3M | $13.4M | 2.8% |
| Energy & Minerals Group Fund IV | — | — | $12.1M | $13.3M | 2.8% |
| New Enterprise Associates 16 | — | — | $10.6M | $13.2M | 2.8% |
| Berkshire Fund IX Coinvestment Fund | — | — | $7.9M | $12.5M | 2.6% |
| Flexpoint Fund IV-A | — | — | $7.9M | $11.2M | 2.3% |
| Battery Ventures XI-A | — | — | $3.1M | $10.7M | 2.2% |
| Accel Growth Fund IV | — | — | $8.2M | $10.5M | 2.2% |
| Resolute IV | — | — | $13.1M | $9.9M | 2.1% |
| Trivest Fund VI | — | — | $7.4M | $9.1M | 1.9% |
| ABS Capital Partners VIII | — | — | $6.6M | $9.0M | 1.9% |
| Gauge Capital II | — | — | $4.6M | $8.8M | 1.8% |
| Accel Leaders Fund | — | — | $1.5M | $8.5M | 1.8% |
| Accel XIII | — | — | $3.9M | $7.4M | 1.6% |
| Battery Ventures XI-A Side Fund | — | — | $1.4M | $6.7M | 1.4% |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value ABRY Heritage Partners | — | — | $4.4M | $5.0M | 1.1% |
| KPCB Digital Growth III | — | — | $6.3M | $4.8M | 1.0% |
| Water Street Healthcare Partners IV S LP | — | — | $3.1M | $4.7M | 1.0% |
| Enlink Midstream | — | — | $3.2M | $4.6M | 1.0% |
| Pegasus WSJLL Fund LP | — | — | $3.3M | $3.9M | 0.8% |
| Inmar, Inc. | — | — | $1.7M | $3.6M | 0.7% |
| Ascent Resources, LLC | — | — | $2.0M | $3.1M | 0.6% |
| Flexpoint Overage Fund IV-A | — | — | $2.7M | $3.0M | 0.6% |
| PDC Opportunities III B | — | — | $160K | $3.0M | 0.6% |
| Energy & Minerals Group Fund III | — | — | $5.1M | $2.9M | 0.6% |
| Harrison Metal V | — | — | $7.8M | $2.4M | 0.5% |
| Plains All American Pipeline, L.P. | — | — | $1.8M | $2.3M | 0.5% |
| Oak HC/FT Partners | — | — | $1.5M | $2.2M | 0.5% |
| Behrman Capital VI | — | — | $1.6M | $1.9M | 0.4% |
| CVC Capital Partners VI | — | — | $1.3M | $1.7M | 0.3% |
| Ten-X | — | — | $955K | $1.5M | 0.3% |
| Noramco Inc. | — | — | $1.7M | $1.4M | 0.3% |
| CIVC Partners Fund V | — | — | $599K | $1.1M | 0.2% |
| Inmar, Inc. | — | — | $423K | $889K | 0.2% |
| Excelitas 1 | — | — | $324K | $832K | 0.2% |
| ABS Capital Partners VII | — | — | $5.0M | $745K | 0.2% |
| Apollo Overseas Partners VIII | — | — | $1.6M | $717K | 0.1% |
| Oaktree Opportunities Fund X | — | — | $97K | $690K | 0.1% |
| Summit Partners Growth Equity Fund VIII-A | — | — | $1.1M | $531K | 0.1% |
| ACP Investment Fund | — | — | $4.7M | $473K | <0.1% |
| ReMarkets | — | — | $499K | $467K | <0.1% |
| ACP Investment Fund II | — | — | $657K | $369K | <0.1% |
| Prairie V 0 | — | — | — | $351K | <0.1% |
| PDC Opportunities VII A | — | — | $108K | $346K | <0.1% |
| FTV IV 0 | — | — | — | $244K | <0.1% |
| Energy & Minerals Group Fund II | — | — | $253K | $241K | <0.1% |
| TA Associates XI 0 | — | — | — | $238K | <0.1% |
| Welsh, Carson, Anderson & Stowe XII | — | — | $111K | $112K | <0.1% |
| Adams Street 2016 US Fund LP 2024 Form 5500, Schedule H FEIN 37-1794596, Plan Number 001 Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value NGP Natural Resources X | — | — | $73K | $91K | <0.1% |
| Madison Dearborn Capital Partners VI | — | — | — | $91K | <0.1% |
| CIVC Partners Fund IV | — | — | $1.4M | $89K | <0.1% |
| JPMorgan US Government Money Market Fund | — | — | $82K | $82K | <0.1% |
| FTVentures III | — | — | $106K | $68K | <0.1% |
| Rimini Street, Inc. - Invested through Adams Street Growth | — | — | $106K | $41K | <0.1% |
| Sequel | — | — | $1.8M | $33K | <0.1% |
| Luxe II | — | — | $13K | $20K | <0.1% |
| Clearview Capital II 0 | — | — | — | $9K | <0.1% |
| Welsh, Carson, Anderson & Stowe XI | — | — | $1.1M | $9K | <0.1% |
| PDC Opportunities V LP 0 | — | — | — | $1K | <0.1% |
